Malaria vaccine difficult to roll out because four doses are needed, WHO saysBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5706 (Published 26 October 2015) Cite this as: BMJ 2015;351:h5706
- Anne Gulland
An antimalaria vaccine for children will be piloted in up to five demonstration sites before being recommended for widespread use, a World Health Organization expert committee has announced.
A phase III trial showed that the RTS,S vaccine, which acts against Plasmodium falciparum, had an efficacy of around 30%.1 The vaccine, which is most effective in children aged between 5 months and 17 months, is given in three …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial